RECENT NEWS
StatLab launches self-manufactured premium slide range
StatLab Medical Products has launched a new self-manufactured premium slide and coverglass brand. The KT premium slides are designed for high-performance in busy pathology laboratories.
Roche launches its first TAGS test, able to detect 12 respiratory viruses
Roche has launched the cobas Respiratory flex test, the first to use Roche’s novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology. It is able to detect up to 12 of the most common respiratory viruses with the flexibility for targeted testing.
MHRA opens AI Airlock regulatory sandbox for applications
The Medicines and Healthcare products Regulatory Agency (MHRA), is calling for applications for manufacturers and developers of Artificial Intelligence (AI) medical devices, to join the AI Airlock regulatory sandbox.
NHSBT team discovers new blood group system, MAL
A research team led by NHS Blood and Transplant scientists based in Bristol, at NHSBT’s International Blood Group Reference Laboratory (IBGRL), and supported by colleagues at the University of Bristol, has discovered a new blood group, MAL, solving a 50-year-old mystery.
Digital bone marrow imaging and analysis added to Beckman Coulter and Scopio Labs partnership
Beckman Coulter and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, have announced expansion of their long-term partnership to include a global distribution agreement forScopio’s Full-Field Bone Marrow Aspirate (FF-BMA) application.
New survey highlights disease outbreak concerns
A new survey from Abbott shows that leading infectious disease experts around the world believe significant gaps remain in building surveillance programmes to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.
Pharmacy-led diabetes screening could save NHS £50m a year
A Company Chemists’ Association (CCA) report urges the NHS to commission a community pharmacy diabetes screening service which would save the NHS £50m in recurring costs each year.
IBMS and Hologic collaborate on new digital cytology report
The Institute of Biomedical Science (IBMS) has collaborated with Hologic to produce a new report on digital cytology which it says promises enhanced efficiency, improved patient care, and solutions to workforce shortages, amid critical challenges in the UK's cervical screening programme.
‘Lung on a chip’ a new tool to combat coronavirus
Researchers from the Quadram Institute working together with the UK Health Security Agency (UKHSA) have established a human ‘lung-on-chip’ model that recreates how SARS-CoV-2 infects lung cells, in a contained laboratory environment.
Imperial College London developing groundbreaking sepsis test
Diagnostic firm MicrosensDx is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis. Based on MicrosensDx’s IP and technology, and designed to fit with existing diagnostic processes, this test could potentially fill a critical gap in patient management, offering clinicians a specific, quantitative diagnostic and prognostic solution to help prioritise appropriate treatment of sepsis.
Generative AI takes on clinical predictions in cancer
A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual colorations of cancer tissue. The study, co-led by scientists at the Universities of Lausanne and Bern, is a major step forward enhancing pathology analysis and diagnostics of cancer.
Roche opens Pharma Research and Development Center in Basel
Roche has opened its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland. Equipped with cutting-edge technologies and housing around 1,000 state-of-the-art laboratory and office workplaces, the new centre brings together teams of scientists and researchers to accelerate scientific discoveries for patients.
Darzi review: IBMS and BIVDA respond
Following the publication of Lord Darzi’s report into the NHS, the Institute of Biomedical Science (IBMS) and British In Vitro Diagnostics Association (BIVDA) have issued responses.
PM: ‘Major surgery, not sticking plaster solutions' needed to rebuild NHS
The Prime Minister Sir Keir Starmer is pledging the ‘biggest reimagining of our NHS since its birth’, following the publication of Lord Darzi’s full and independent investigation into the state of the NHS.
The latest issue of Pathology in Practice is now available!
The September issue of PiP has now been published and is available to read online.
Novel point-of-care heart attack test leads to shorter emergency department stays
A new, rapid blood test that spots whether people are having a heart attack could improve the treatment of people presenting with chest pain at emergency departments, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London.
Sophia Genetics partners with AstraZeneca to expand liquid biopsy access
Sophia Genetics has announced a new partnership agreement with AstraZeneca, which will accelerate the deployment of the liquid biopsy test MSK-ACCESS powered with SOPHiA DDM to 20 locations worldwide over the next 12 months.
Experimental blood test predicts COPD risk
A scientific team supported by the National Institutes of Health (NIH) has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD).
Fimlab moves towards AI-enabled pathology with Proscia
Fimlab Laboratories, Finland’s largest provider of laboratory services, research, and training, is taking the next step on its digital pathology journey with Proscia, a global leader in AI-enabled pathology solutions for precision medicine. The company will use Proscia’s software platform to help its pathologists generate more precise results with artificial intelligence (AI).
Nucleix partners with Menarini for Bladder EpiCheck
A Menarini Diagnostics and Nucleix have announced a long-term commercial agreement for the exclusive distribution of the Bladder EpiCheck test in Europe. Under the new agreement, Menarini will assume exclusive marketing of the non-invasive Bladder EpiCheck test in Europe in the months ahead, aiming to accelerate its adoption.
Latest Issues
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
37th European Congress of Pathology
ACV, Vienna, Austria
6 -10 September, 2025